RxDoctor Payments Data

Greg Davis, MD

Otolaryngology · Puyallup, WANPI 1679689145

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Medtronic at 31.8% of the total. Among otolaryngology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$530,784in general payments, 2019–2025

Across 636 payments — averaging $834.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$169K
  • Neurent Medical Limited$117K
  • Intersect ENT, Inc.$109K
  • Aerin Medical Inc.$37K
  • Stryker$29K
  • Optinose US, Inc.$17K
  • plus $53K from 26 others
$589,600in research payments, 2019–2025

Across 81 payments — averaging $7279.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurent Medical Limited$568K
  • Aerin Medical Inc.$22K

What the payments were for

  • Consulting fees$281,87253%
  • Speaking & faculty fees$150,00828%
  • Grants$1,7500%
  • Travel & lodging$74,32014%
  • Food & beverage$22,8344%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$530,784 in reported general payments places this provider in the 95th percentile of 254 otolaryngology providers in Washington.

See all otolaryngology providers in Washington

Medicare billing

Part B allowed, 2024
$152,688
Medicare patients
149
Services billed
1,197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab18$79,433
Dupixent SyringeDupilumab13$49,857
Ipratropium Bromide98$3,439
Doxycycline Hyclate44$630
Azithromycin40$211
Mupirocin16$80
Oxycodone Hcl19$33
Prednisone13$24
Ondansetron Hcl20$20

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Puyallup

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →